Global Message Icon  

Skip main navigation (Press Enter).
Society for Immunotherapy of Cancer (SITC) logo. This will take you to the homepage
Society for Immunotherapy of Cancer (SITC) logo. This will take you to the homepage
Log in
Log in
  • Education & Science
    • 40th Annual Meeting & Pre-Conference Programs
    • Past and Future Annual Meetings
    • Advances in Cancer Immunotherapy
    • SITC Biotech Initiative
    • SITC Biotech Strategic Meeting at NYSE
    • SITC Biotech Virtual Programs
    • SITC Neoadjuvant Initiatives
    • Cancer Immunotherapy Winter School
    • Spring Scientific
    • Collaborative Education Programs
    • Patient & Survivor Resources
    • Webinars and Virtual Workshops
    • Upcoming Events
  • Career Development
    • Certificate in Cancer Immunotherapy
    • Fellowships
    • Women in Cancer Immunotherapy Network
    • Sparkathon
    • SITC Clinical Immuno-Oncology Network (SCION) Workshop
    • Clinical Trials Training and Resources
    • Early Career Scientist (ECS) Committee
    • Path to SITC Leadership
  • Publications & Guidelines
    • Journal for ImmunoTherapy of Cancer
    • SITC Clinical Practice Guidelines
    • SITC Immunotherapy Books
    • SITC Scientific Publications News
  • About
    • Mission & Vision
      • Strategic Initiatives
    • Strategic Plan
      • Elevating a Rich Oncology Community
    • Board of Directors
    • Committees, Task Forces, & Communities
    • Awards and Recognition
    • Academy of Immuno-Oncology
    • SITC Policies
    • Contact SITC
    • SITC News
    • Cancer Immunotherapy Month
  • Get Involved
    • Join SITC
      • Connect-a-Colleague
      • Corporate Membership
      • International Membership
      • Member Directory
    • Support SITC
    • Policy & Advocacy
    • 2025 SITC Election
    • Committees, Task Forces, & Communities
    • Career Connections
    • Volunteer with SITC
    • SITC Resource Library
    • Events
    • For Patients
  • Join
  • Renew
  • Donate
  • My Libraries

2024 Cancer Immunotherapy Winter School Schedule

Winter School Main Page Register Now On-demand Content Contact Us Back to Top ↑

Select a day >


Monday, Jan. 29

Tuesday, Jan. 30

Wednesday, Jan. 31

Thursday, Feb. 1

Friday, Feb. 2

2024 Cancer Immunotherapy
Winter School Schedule

JAN. 30–FEB. 2, 2024  |  AUSTIN, TX AND VIRTUAL

The following is the schedule for the 2024 SITC Cancer Immunotherapy Winter School, taking place Jan. 30-Feb. 2, 2024.

Monday, Jan. 29, 2024

5-7 p.m. CT

Early Registration and Badge Pick Up

Tuesday, Jan. 30, 2024

 Indicates that the presentation is not available on-demand.

 

7-8 a.m. CT

Registration

8–9 a.m. CT

 Immunotherapy Overview: History of the Field
Yana Najjar, MD - University of Pittsburgh

9-9:05 a.m. CT

Transition Time

9:05–10:05 a.m. CT

Innate Immunity: Cellular Mechanisms and Signaling
Lewis Lanier, PhD - University of California San Francisco

10:05–10:20 a.m. CT

Break

10:20-11:20 a.m. CT

 Adaptive Immunity: Cellular Mechanisms and Signaling
Kristin Anderson, PhD - University of Virginia 

11:20-11:25 a.m. CT

Transition Time

11:25 a.m.–12:25 p.m. CT

 Tumor Microenvironment: Complexity of Cells and Molecules Regulating Intratumoral Immunity
Victor Engelhard, PhD -  University of Virginia School of Medicine

12:25–1:25 p.m. CT

Networking Lunch

1:25–2:25 p.m. CT


 Tumor Immunosuppression Mechanisms
Greg Delgoffe, PhD - University of Pittsburgh

2:25-2:30 p.m. CT

Transition Time

2:30-3:30 p.m. CT

 Tumor Immunology, Immunoregulation, and Immunopharmacodynamics
Jan Joseph Melenhorst, PhD - Cleveland Clinic

3:30-3:45 p.m. CT

Break

3:45-4:45 p.m. CT

Immunotherapeutic Strategy: Immune Checkpoint Blockade

Sumit Subudhi, MD, PhD - The University of Texas MD Anderson Cancer Center

4:45-4:50 p.m. CT

Transition

4:50-5:20 p.m. CT

 Patient Considerations that Impact Treatment and Clinical Trials

Deborah Collyar, BS - Patient Advocates in Research

5:20-5:25 p.m. CT

Transition

5:25-6:25 p.m. CT

Breakout Session: Antigen Presentation 
Peter Bruno, PhD - University of California San Francisco

 Breakout Session: T Cell Exhaustion
Greg Delgoffe, PhD - University of Pittsburgh

Breakout Session: Innate Immune Mechanisms Dendritic Cells and NK Cells
Lewis Lanier, PhD -  University of California San Francisco

Wednesday, Jan. 31, 2024

Indicates that the presentation is not available on-demand.

 

7:30-8 a.m. CT 

Registration

8–9 a.m. CT

 Grantsmanship
Christian Capitini, MD - University of Wisconsin-Madison

9-9:05 a.m. CT

Transition

9:05–10:05 a.m. CT

 Presenting Your Data in Talks and Manuscripts

Melody Smith, MD, MS - Stanford University

10:05–10:20 a.m. CT

Break

10:20-11:20 a.m. CT

Preclinical Assessment of Cell and Gene Therapy Products to Support IND
Y. Maurice Morillon, PhD - U.S. Food and Drug Administration

11:20-11:25 a.m. CT

Transition Time

11:25 a.m.–12:25 p.m. CT

 Immunotherapeutic Strategy: Adoptive Cell and CAR T Therapies
Christian Capitini, MD - University of Wisconsin-Madison

12:25–1:25 p.m. CT

Networking Lunch

1:25–2:25 p.m. CT

 B Cells and TLS
Tullia Bruno, PhD -  University of Pittsburgh

2:25-2:30 p.m. CT

Transition Time

2:30-3:30 p.m. CT

Immunotherapeutic Strategy: Can Cancer Vaccines Really Work?
Olivera Finn, PhD - University of Pittsburgh

3:30-3:45 p.m. CT

Break

3:45-4:45 p.m. CT

 How to Work with Patient Representatives to Make Your Research More Successful

Deborah Collyar, BS - Patient Advocates in Research

4:50-5:50 p.m. CT

Breakout Session: Cytokine-based Immunotherapies and Other Molecular Bispecifics, Other Immunotherapies
Michael T. Lotze, MD, FACS - University of Pittsburgh

 Breakout Session: Importance of T Cell Subsets
Chrystal Paulos, PhD - Winship Cancer Institute at Emory University

 Breakout Session: The Microbiome and Immunotherapy
Melody Smith, MD, MS - Stanford University

6-7:30 p.m. CT

CIWS and SCION Reception

Thursday, Feb. 1, 2024

Indicates that the presentation is not available on-demand.

 

 

7:30-8 a.m. CT

Registration

8-9 a.m. CT

 Data and Statistical Analyses: Analyzing Basic and High Throughput Datasets
Dinesh Kumar, PhD - Roche

9-9:05 a.m. CT

Transition

9:05–10:05 a.m. CT

 Researcher: Antigen Identification
Paul F. Robbins, PhD - National Cancer Institute, National Health Institutes

 Clinician: Phase I Immunotherapy Clinical Trials 
Chris Takimoto, MD, PhD - IGM Biosciences

10:05–10:20 a.m. CT

Break 

10:20–11:20 a.m. CT

Researcher: Pre-Clinical Animal Models
Maryland Franklin, PhD - Labcorp

Clinician: Phase II and Phase III Immunotherapy Clinical Trials
Elizabeth Garrett-Mayer, PhD - American Society of Clinical Oncology

11:20-11:25 a.m. CT

Transition 

11:25 a.m.–12:25 p.m. CT

Researcher: Regulatory Issues Related to Cancer Immunotherapy
Bambi Grilley, RPh - Baylor College of Medicine

Clinician: How to Get a Predictive Biomarker out of every Clinical Trial
Gregory Lesinski, PhD, MPH - Winship Cancer Institute at Emory University


12:25–1:25 p.m. CT

Networking Lunch

1:25–2:25 p.m. CT

 Researcher: Tumor Cell Analyses (Pathology)
Tricia Cottrell, MD, PhD - Queen's University

 Clinician: Autoimmunity and irAEs
Ryan Sullivan, MD - Harvard Medical School and Massachusetts General Hospital

2:25-2:30 p.m. CT

Transition 

2:30–3:30 p.m. CT

Researcher: Applications of Computational Biology/Machine Learning to Immuno-Oncology
Robert Scharpf, PhD - Johns Hopkins University

Clinician: Biomarker-Based Clinical Trial
Jianda Yuan, MD, PhD - Merck Research Laboratories

3:30–3:45 p.m. CT

Break

3:45–4:45 p.m. CT

 Breakout Session: Deep TCR and BCR Sequencing as a Biomarker for Cancer
Sacha Gnjatic, PhD - Icahn School of Medicine at Mount Sinai

 Breakout Session: Industry-Led Session: New Agents 
Chris Takimoto, MD, PhD - IGM Biosciences

 Breakout Session: TCR T Cell Therapy
Kristin Anderson, PhD -  University of Virginia

Friday, Feb. 2, 2024

Indicates that the presentation is not available on-demand.

 

 

7:30-8 a.m. CT

 Registration

8-9 a.m. CT

 Intratumoral and Local Therapy

Masataka Suzuki, PhD - Baylor College of Medicine

9-9:05 a.m. CT

Transition

9:05–10:05 a.m. CT

Researcher: Synthetic Immunology: Harnessing the Tools of Synthetic Biology and Gene Editing to Engineer Next-Generation Cell Therapies
Justin Eyquem, PhD - University of California San Francisco

Clinician: Immunotherapy in Special Patient Populations
Ned Waller, MD, PhD - Emory University 

10:05–10:20 a.m. CT

Break 

10:20–11:20 a.m. CT

Researcher: Pre-Clinical Combination Therapy
Gregory Lesinski, PhD, MPH - Winship Cancer Institute Emory University

 Clinician: Off-the-Shelf Cell Products
May Daher, MD - The University of Texas MD Anderson Cancer Center

11:20-11:25 a.m. CT

Transition 

11:25 a.m.–12:25 p.m. CT

 Researcher: How to Handle Big Data and High Throughput Data
Dinesh Kumar, PhD - Roche

Clinician: Combination Immunotherapies
Bambi Grilley, RPh - Baylor College of Medicine


12:25–1:25 p.m. CT

Networking Lunch

1:25–2:25 p.m. CT

GMP: The Science of Manufacturing
Bruce Levine, PhD - Abramson Cancer Center

2:25-2:30 p.m. CT Transition

2:30-3:30 p.m. CT

 Breakout Session: Development of a Grant/Translational Idea and Career Development Awards
Sumit Subudhi, MD, PhD - The University of Texas MD Anderson Cancer Center
Christian Capitini, MD - University of Wisconsin-Madison

Breakout Session: Methods to Assess and Discover Biomarkers 
Jianda Yuan, MD, PhD - Merck Research Laboratories

 Breakout Session: Hands on Dataset Analysis (Bring Your Own Datasets)
Panagiotis Benos, PhD - University of Florida

3:30-3:45 p.m. CT

Break

3:45-4:45 p.m. CT

Careers in Cancer Immunotherapy Panel Discussion

Chris Takimoto, MD, PhD - IGM Biosciences

Y. Maurice Morillon, PhD - U.S. Food and Drug Administration

Chrystal Paulos, PhD - Winship Cancer Institute at Emory University

4:45-4:50 p.m. CT

Transition

4:50-5:50 p.m. CT

 Perspective on the Field
Christian Capitini, MD - University of Wisconsin-Madison

On-Demand Content

Program registrants receive complimentary access to on-demand content. 

On-demand content is available for purchase for those who did not register to attend the program. A discount is available for SITC Members. Renew your dues or become a SITC member today.

ENDURING MATERIALS NOW AVAILABLE!

Enduring Materials (slides and recorded videos) for the 2023 Cancer Immunotherapy Winter School are now available as permitted by presenters. Presentations can be accessed by visiting the 2023 Cancer Immunotherapy Winter School Library.  

  • Cancer Immunotherapy Winter School attendees will have access to presentation slides through the virtual meeting platform for one month following the program. In addition, attendees will have access to recorded videos and slides, as permitted by presenters, through the 2023 Cancer Immunotherapy Winter School Library. At this time, non-attendees will have the ability to purchase access to the enduring materials.
  • SITC members will receive access to the enduring materials, as permitted by presenters, beginning February 28, 2022.
  • The enduring materials, as permitted by presenters, will be available to the public on February 28, 2023.

SITC is committed to sharing presentations from its programs for the advancement of the field but respects faculty requests to maintain confidentiality of their unpublished data and therefore has redacted slides or restricted access to presentations with this symbol: .

If you have questions about 2023 Cancer Immunotherapy Winter School enduring materials, please contact education@sitcancer.org.

Contact

555 East Wells Street, Suite 1100 | Milwaukee, WI | 53202-3823 | USA

Phone

+1 414 271 2456

Popular Links

  • Become a SITC Member
  • SITC 2025
  • SITC Account Login

Community Links

  • SITC Communities
  • Upcoming Events
  • Enduring Materials

Legal

  • Meeting Code of Conduct
  • Financial Conflicts of Interest (FCOI) Policy
  • Privacy Policy & Website Terms of Use

© All Rights reserved.

Powered by Higher Logic

Copyright 2025. All rights reserved.
Powered by Higher Logic
Global message icon